Skip to main content
Premium Trial:

Request an Annual Quote

George Mason CLIA Lab to Use Aushon Arrayer to Study PGx-Based Cancer Rxs

NEW YORK (GenomeWeb News) — George Mason University will use an Aushon Biosystems 2470 arrayer to study targeted cancer treatments, the company said today.
 
George Mason has installed the 2470 in a CAP-CLIA laboratory that focuses on clinical trials for cancer treatments based on protein expression profiles.
  
Financial terms of the agreement were not released.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.